We are live on ! Find out more
DAVA icon

Endava

182 hedge funds and large institutions have $958M invested in Endava in 2024 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 60 increasing their positions, 64 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more call options, than puts

Call options by funds: $5.99M | Put options by funds: $4.5M

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

6% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 64

3.42% less ownership

Funds ownership: 83.72%80.3% (-3.4%)

7% less funds holding

Funds holding: 196182 (-14)

26% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 50

26% less capital invested

Capital invested by funds: $1.3B → $958M (-$341M)

Holders
182
Holders Change
-14
Holders Change %
-7.14%
% of All Funds
2.63%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
37
Increased
60
Reduced
64
Closed
50
Calls
$5.99M
Puts
$4.5M
Net Calls
+$1.49M
Net Calls Change
+$139K

DAVA Hedge Fund Activity: Q2 2024 in Review

182 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Endava (DAVA) for Q2 2024, worth a combined $958M — down 26% from $1.3B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of DAVA and 37 opened new positions — a net loss of 13 holders — while 64 trimmed existing stakes and 60 added.

The largest buyer was Invesco, adding an estimated $64.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $97.6M.

  • 182 institutional investors held Endava (DAVA) as of Q2 2024, down from 196 in Q1 2024.
  • Funds reported $958M of Endava stock for Q2 2024, down 26% quarter-over-quarter.
  • 37 funds opened new Endava positions in Q2 2024 and 50 closed out, a net change of -13 holders.
  • The largest Endava buyer in Q2 2024 was Invesco, an estimated $64.4M added.
  • The largest Endava seller in Q2 2024 was T. Rowe Price Associates, an estimated $97.6M sold.

Based on aggregated 13F filings for Q2 2024.